Funded Startups in San Antonio
Disclosed funding in San Antonio is heavily skewed: the largest disclosed round is Howard Energy Partners’ $750M (2025-08-05), far above the next-largest d…
Disclosed funding in San Antonio is heavily skewed: the largest disclosed round is Howard Energy Partners’ $750M (2025-08-05), far above the next-largest disclosed amounts in the table (e.g., EPIC’s $1.2B appears later in the list but is still within the same city set; among other disclosed entries outside the top tier, many are in the $1M–$30M band). At the small end, Vascular Perfusion Solutions shows $30K (2023-12-07), with several other early-stage/low-ticket rounds clustering around $20K–$300K (e.g., Allosense Inc. at $20K on 2023-04-04; Klarisana at $300K on 2023-08-02). Temporally, rounds span 2020-07-22 (Irys) through 2025-11-11 (MR3Health), with a dense late-2025 concentration: at least four entries land between 2025-07-18 and 2025-08-19 (e.g., HighPoint Partners LLC $101M on 2025-07-18; LiftFund $2M on 2025-07-22; BioAffinity Technologies $1M on 2025-08-12). Sector and classification are mixed: Energy and Biotechnology each appear in multiple rows (Energy is repeated across Howard Energy Partners, HighPoint Partners LLC, EPIC, and Renu Robotics; Biotechnology across BioAffinity Technologies, Texas Biomedical Research Institute, EO2 Concepts, Hera Biotech, Emtora Biosciences, and Vascular Perfusion Solutions), while “Series Unknown” dominates labels (25 of 47), complemented by several explicit “undisclosed” amounts (12 of 47).
Most recent rounds
47 shownRelated listings
Frequently asked
Which disclosed round stands out most in this San Antonio set, and how does it compare to the rest of the disclosed figures?
The largest disclosed amount is Howard Energy Partners at $750M on 2025-08-05, and it sits well above most other disclosed rounds, which frequently fall into the $1M–$30M range (e.g., Texas Biomedical Research Institute $3M on 2024-05-14; Pineapple $21M on 2023-11-15). At the low end, Vascular Perfusion Solutions is listed at $30K on 2023-12-07, illustrating a wide dispersion between the top-tier and bottom-tier disclosed amounts.
Are there clear funding clusters in the most recent window (e.g., late 2025), or is the timing spread evenly?
The list is not uniform over time: multiple rounds cluster in mid-to-late 2025, including HighPoint Partners LLC ($101M on 2025-07-18), LiftFund ($2M on 2025-07-22), BioAffinity Technologies ($1M on 2025-08-12), and Howard Energy Partners ($750M on 2025-08-05). The overall date span runs from 2020-07-22 (Irys) to 2025-11-11 (MR3Health), but the newest entries are packed toward 2025.
What stage labeling pattern dominates, and does it limit confidence when comparing “largest rounds” across companies?
“Series Unknown” is the most common label with 25 of 47 entries, and “undisclosed” appears in 12 of 47 amount fields, so comparisons are frequently constrained by missing round-stage and missing dollar disclosure. Examples include Streamline Innovations (undisclosed amount on 2025-08-19) and Project QUEST (undisclosed on 2025-06-18), which prevents ranking by disclosed size for a meaningful subset.
Which sectors recur most often in this city listing, and where do they show up chronologically?
Energy and Biotechnology are the two most repeated sectors in the rows shown: Energy appears in multiple entries such as Howard Energy Partners (2025-08-05, $750M), HighPoint Partners LLC (2025-07-18, $101M), and EPIC (2024-10-16, $1.2B), while Biotechnology appears in BioAffinity Technologies (2025-08-12, $1M), Texas Biomedical Research Institute (2024-05-14, $3M), and Emtora Biosciences (2022-08-19, grant amount $17M). This creates parallel sector “threads” spanning both the newest rounds (2024–2025) and earlier rounds (2022–2023).
Are there outliers beyond funding size, such as very early-stage rounds or unusually low disclosed tickets?
Yes—low-disclosed outliers sit far below the dominant $1M–$30M band. Vascular Perfusion Solutions is $30K on 2023-12-07, Allosense Inc. is $20K on 2023-04-04, and Range Rehab is $20K on 2022-10-18, all contrasted with much larger disclosed rounds like EPIC’s $1.2B on 2024-10-16. These extremes suggest a mix of late-growth financings and early-leaning or selectively disclosed deals within the same city list.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.